Notable Labs Inc.
Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically … Read more
Notable Labs Inc. (NTBL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: -0.516x
Based on the latest financial reports, Notable Labs Inc. (NTBL) has a cash flow conversion efficiency ratio of -0.516x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.71 Million) by net assets ($7.19 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Notable Labs Inc. - Cash Flow Conversion Efficiency Trend (2019–2023)
This chart illustrates how Notable Labs Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Notable Labs Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Notable Labs Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SINGAPORE AIRLINES - Dusseldorf Stock Exchang
DU:SIA1
|
0.011x |
|
BLE Kedros R.E.I.C.
AT:BLEKEDROS
|
0.043x |
|
Ashtead Technology Holdings PLC
LSE:AT
|
0.153x |
|
Asta Co. Ltd.
KO:246720
|
N/A |
|
DongBang Medical
KQ:240550
|
N/A |
|
CONTACT ENERGY
BE:BZB
|
N/A |
|
BOLLORE (BOP.SG)
STU:BOP
|
0.007x |
|
LIBERTY INT QVC-A (LB3A.SG)
STU:LB3A
|
0.042x |
Annual Cash Flow Conversion Efficiency for Notable Labs Inc. (2019–2023)
The table below shows the annual cash flow conversion efficiency of Notable Labs Inc. from 2019 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $15.11 Million | $-13.72 Million | -0.908x | -388.17% |
| 2022-12-31 | $-36.97 Million | $-11.64 Million | 0.315x | +12.85% |
| 2021-12-31 | $-53.94 Million | $-15.05 Million | 0.279x | +136.90% |
| 2020-12-31 | $30.92 Million | $-23.38 Million | -0.756x | -108.11% |
| 2019-12-31 | $36.02 Million | $-13.09 Million | -0.363x | -- |